AzTrials
AzTrials

DementiaNCT05883527

Partnership in Safeguarding People With Dementia From Primary and Social Care Perspectives

An observational study of Dementia and Abuse Client, run by University of Manchester at 5 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

"Adult safeguarding is everyone's responsibility". The Care Act 2014 makes safeguarding a legal duty. It provides local authorities and other agencies in England with a responsibility to protect adults with care and support needs from abuse and neglect. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Not applicable as not an intervention - PLwD and family/carers and Not applicable as not an intervention - HCP's
How many people
37 participants
Where
5 sitesUnited Kingdom
Study dates
1 May 2023to 31 Mar 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Tentatively this study will aim to recruit 20-30 health and social care professionals (interviews-20, focus groups-10) making referrals via GP's who have experiences of safeguarding in the context of dementia. This study also aims to recruit between 15-20 people with dementia and carers/family members involved in safeguarding, who will be accessed via primary and social care practitioners.

Who may be able to join

  • Health and social care professionals:
  • GPs, Nurses, social workers, mental health professionals, support workers, IMCA (independent mental capacity advocates) and other health care professionals in GP surgeries and integrated social care hubs with experience in facilitating safeguarding.
  • Safeguarding lead in GP surgeries, social care organisations and other organisations (advocacy agencies).
  • Professionals from third-sector organisations who have previously raised safeguarding concerns regarding adults living with Dementia
  • Service users and carers/family:
  • People with dementia who have been involved in the safeguarding process, with mental capacity to consent.
  • Family members of people with dementia who have been previously involved in the safeguarding process
  • Individuals who were involved in a safeguarding inquiry in the past, which is NOT ongoing at the time of interview.

Who cannot join

  • Health and social care professionals at GP practices, social care organisations and third sector organisations without experiences of safeguarding older adults and unwilling to participate in the study.
  • People with dementia who lack capacity to consent.
  • Individuals involved in an active and ongoing safeguarding inquiry.

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United Kingdom5 sites
  • CRN

    Leeds

  • Leeds Local Authority

    Leeds

  • CRN

    Manchester

  • Greater Manchester Local Authority

    Manchester

  • CRN

    Southport

Other trials in United Kingdom

About this study

"Adult safeguarding is everyone's responsibility". The Care Act 2014 makes safeguarding a legal duty. It provides local authorities and other agencies in England with a responsibility to protect adults with care and support needs from abuse and neglect. This is done most effectively when all relevant agencies work together. This is particularly important for people living with dementia, as they are at higher risk of abuse or neglect. Such abuse is most common in their own homes and care settings. Primary and social care professionals are likely to have regular contacts with older people, hence have opportunities for early identification and prevention of abuse. However, little is known about how primary care practitioners work in partnership with social care and other agencies to investigate and manage abuse.

Aims:

Read more

This project will outline how health professionals in primary care settings understand and respond to abuse and what their understandings of safeguarding law and policy are. It will also identify how social services departments assess and manage referrals relating to people living with dementia in primary care settings. Furthermore, the study will analyse the experiences of people with dementia and families who are at the centre of safeguarding

Methods:

This study has three phases. In phase 1, the investigators will synthesise current research and practice evidence to develop a theory of safeguarding conceptualisation and process. In phase 2, the investigators will analyse national statistics on safeguarding (NHS digital dataset), ageing and dementia data (English Longitudinal Study of Ageing) to understand patterns of reporting and how they vary across location, gender, ethnicity and time period. In phase 3, the investigators will interview GPs, social workers, safeguarding leads, independent advocates, people with dementia, family members, support workers, carers and other professionals who make or receive referrals via primary care. As part of phase 3 group discussions will also be conducted, in which professionals will come together to share their experiences, and will identify approaches for preventing abuse and collaboration amongst relevant agencies. Phase 3 will inform the development of complex case studies, drawing on data from phases 1 and 2.

Impact:

This study will help develop practice guidance for professionals, to aid multi-agency collaboration in safeguarding cases specific to dementia. This will be developed in consultation with the PPIE (Patient and Public Involvement and Engagement) members and practitioners. Videos will also be produced and plain English versions of case studies of complex safeguarding scenarios and strategies in consultation with safeguarding leads, law experts, training providers and other key stakeholders. Experts by experience (working with, caring for or living with dementia), will be able to guide the team with cultural nuances and appropriateness to ensure that the material developed is sensitive to all populations. An info graph/pictograph displaying signs of abuse, staying safe and what to do, aimed at people with dementia and family will be compiled. The investigators will liaise with national safeguarding leads so that this information can be displayed in GP clinics. Furthermore, the investigators will contact social responsibility personnel for supermarkets and discuss the potentials of wider circulation for displaying this information in stores.

Being tested
Not applicable as not an intervention - PLwD and family/carers, Not applicable as not an intervention - HCP's
Keywords
Safeguarding, Abuse, Neglect, Dementia, Health and care professionals, Social care, Section 42
Medical subject headings
Dementia, Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Not applicable as not an intervention - PLwD and family/carersOther

    Exploring the safeguarding process through interviews.

  • Not applicable as not an intervention - HCP'sOther

    Exploring the safeguarding process through interviews and a focus group.

Study groups in NCT05883527
Study groupRoleWhat they receive
Health and Care ProfessionalsGP's, nurses, social workers, mental health professionals, support workers, Independent mental capacity advocates (IMCA), and other HCP's working in GP surgeries and integrated social care hubs. Safeguarding leads in GP surgeries, social care organisations and other relevant organisations. Professionals from third-sector organisations who have previous experience of safeguarding.
Receives: Other: Not applicable as not an intervention - HCP's
People Living with DementiaWho have been involved in the safeguarding process and have capacity to consent.
Receives: Other: Not applicable as not an intervention - PLwD and family/carers
Paid carers of people living with dementiaWho have been involved in the safeguarding process.
Receives: Other: Not applicable as not an intervention - PLwD and family/carers
Family members of people living with dementiaWho have been involved in the safeguarding process.
Receives: Other: Not applicable as not an intervention - PLwD and family/carers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Trends in reporting of routinely collected safeguarding datasets - NHS digital

    Number of reports of safeguarding concerns and section 42 enquiries in England. Type of risks, source of risks, location, age, gender, ethnicity, health condition.

    Measured: September 2022 - March 2024

  2. Trends in reporting of routinely collected safeguarding datasets - ELSA data

    The prevalence of dementia across England, number of older people with dementia in receipt of care and who gave the care in each local authority in England.

    Measured: data years: 2002-2017

  3. Quality Outcomes Framework (QOF) Recorded Dementia Diagnoses

    Rate of dementia diagnosis in each local authority district in England and demographic characteristics of those with dementia diagnosis in each NHS CCG in England.

    Measured: data years: 2021-2022

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2023
  2. Study start1 May 2023
  3. Primary completion6 Feb 2024
  4. Study completion31 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
37 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05883527
Sponsor's protocol ID
IRAS ID: 319897
Status last verified
Oct 2026
First submitted
10 May 2023
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Maharani A, Dixon J, Szulewska K, Robinson C, Cooper M, Panagioti M, Blakeman T, Lasrado R. Geographical and temporal distribution of safeguarding concerns among older adults with dementia in England: a population-based repeated cross-sectional study. BMJ Open. 2026 Aug 26;16(8):e110575. doi: 10.1136/bmjopen-2025-110575.

    PubMed 42648775
  • Lasrado R, Szulewska K, Dixon J, Maharani A, Robinson C, Cooper M, Panagioti M, Blakeman T. Understanding Safeguarding for People Living with Dementia: A Realist Review of Conceptualization and Practice. Trauma Violence Abuse. 2025 Oct 21:15248380251375488. doi: 10.1177/15248380251375488. Online ahead of print.

    PubMed 41117016

Questions about this trial

What is this clinical trial studying?

An observational study of Dementia and Abuse Client, run by University of Manchester at 5 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Trends in reporting of routinely collected safeguarding datasets - NHS digital (time frame: September 2022 - March 2024). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05883527, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in